SW · BANB.SW
Bachem Holding AG
- Sector
- Basic Materials · Chemicals
- Headquarters
- Bubendorf 4416
- Website
- bachem.com
Price · as of 2024-12-31
$70.80
Market cap 4.45B
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $43.63 | -38.38% |
| Intrinsic Value(DCF) | $21.77 | -69.25% |
| Graham-Dodd Method(GD) | $14.57 | -79.42% |
| Graham Formula(GF) | $20.40 | -71.18% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | $6.85 | $24.60 | $1.06 | $2.98 | $0.00 |
| 2011 | $5.67 | $24.45 | $1.29 | $1.78 | $0.52 |
| 2012 | $5.76 | $22.73 | $1.18 | $3.60 | $3.54 |
| 2013 | $7.67 | $23.44 | $0.03 | $2.23 | $5.72 |
| 2014 | $8.49 | $24.71 | $0.00 | $2.07 | $6.71 |
| 2015 | $9.98 | $25.79 | $0.00 | $3.79 | $9.86 |
| 2016 | $21.33 | $30.82 | $0.00 | $3.90 | $12.74 |
| 2017 | $23.06 | $29.35 | $2.01 | $3.30 | $11.25 |
| 2018 | $22.99 | $28.98 | $1.18 | $3.05 | $10.84 |
| 2019 | $30.24 | $29.94 | $0.29 | $4.45 | $14.60 |
| 2020 | $72.20 | $49.64 | $14.87 | $3.37 | $39.16 |
| 2021 | $98.29 | $63.81 | $24.69 | $19.58 | $52.18 |
| 2022 | $85.96 | $52.25 | $4.16 | $12.19 | $18.42 |
| 2023 | $78.91 | $54.29 | $0.00 | $13.88 | $24.50 |
| 2024 | $52.71 | $43.63 | $0.00 | $14.57 | $20.40 |
AI valuation
Our deep-learning model estimates Bachem Holding AG's (BANB.SW) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $43.63
- Current price
- $70.80
- AI upside
- -38.38%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$21.77
-69.25% upside
Graham-Dodd
$14.57
-79.42% upside
Graham Formula
$20.40
-71.18% upside
About Bachem Holding AG
Bachem Holding AG provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. The company engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). It also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. The company was founded in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.
- CEO
- Peter Grogg
- Employees
- 2.21K
- Beta
- 1.07
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($21.77 ÷ $70.80) − 1 = -69.25% (DCF, example).